Skip to main content

Table 1 Baseline characteristics at inclusion

From: Effect of an analgo-sedation protocol for neurointensive patients: a two-phase interventional non-randomized pilot study

 

Observational period

(n = 106)

Intervention period

(n = 109)

P Value

Male, n (%)

73 (69%)

65 (60%)

.159

Female, n (%)

33 (31%)

44 (40%)

.159

Age, mean years (SD)

55 (15)

52 (17)

.100

Weight, mean kg (SD)

78 (14)

75 (16)

.267

APACHE II, mean score (SD)

20 (4)

21 (5)

.477

SAPS II, mean score (SD)

51 (10)

50 (11)

.500

SOFA, mean score (SD)

8 (2)

8 (2)

.707

Diagnosis, n (%)

  

.186

   SAH/ICH

50 (47%)

37 (34%)

 

   SDH/TBI

37 (35%)

41 (38%)

 

   Other

19 (18%)

30 (28%)

 
  1. Sex and diagnosis (Chi-Square test); age, weight, APACHE II, SAPS II, SOFA (t-test); and P value ≤ .05 significant.
  2. ICH: intracerebral hemorrhage; SAH: subarachnoid hemorrhage; SDH: subdural hematoma; TBI: traumatic brain injury. Other: Medullar lesion, status epilepticus, neuromuscular disease, tumors, infections.
Back to article page

Critical Care

ISSN: 1364-8535